TECH · 10-Q/A · 2026Q3 · Full report

Operating Margin Drivers

BIO-TECHNE Corp · 2026-11-12 · Importance 59 · Surprise 48

Gross margin increased 4.5% to $196.6 million, but gross margin as a share of revenue edged down to 65.6% from 65.7%. Operating income declined 23.2% to $36.6 million from $47.7 million, reducing operating margin to 12.2% from 16.6%. Consolidated operating income included $17.8 million of acquisition-related expenses and other costs, $14.7 million of intangible amortization, $14.8 million of stock-based compensation, and $3.8 million of restructuring and restructuring-related costs in the September 2026 quarter.

Key facts

• Bio-Techne’s non-GAAP adjusted net earnings were $70.105 million and adjusted diluted earnings per share were $0.44 for the quarter ended September 30, 2026. source
• Consolidated GAAP gross margin was 65.6% in the quarter ended September 30, 2026, unchanged from the prior-year quarter; adjusted gross margin was 69.3% versus 70.2%. source